Top Banner
PROBLEM SPACE Breast Cancer: What Are The Risks? Audience: GenEd Biology students Linda Grisham, Massachusetts Bay Community College Mark Maloney, Spelman College Kim Gernert, Emory University
35

PROBLEM SPACE Breast Cancer: What Are The Risks?

Feb 07, 2016

Download

Documents

triage

PROBLEM SPACE Breast Cancer: What Are The Risks?. Audience : GenEd Biology students. Linda Grisham, Massachusetts Bay Community College Mark Maloney, Spelman College Kim Gernert , Emory University. Inspired by the recent Angelina Jolie health disclosures. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

PROBLEM SPACE Breast Cancer: What Are The Risks?

Audience: GenEd Biology students

Linda Grisham, Massachusetts Bay Community CollegeMark Maloney, Spelman CollegeKim Gernert, Emory University

Page 2: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Inspired by the recent Angelina Jolie health disclosures.

http://www.cnn.com/2013/05/14/showbiz/angelina-jolie-double-mastectomy

(CNN) -- Actress Angelina Jolie announced in a New York Times op-ed article on Tuesday that she underwent a preventive double mastectomy after learning that she carries a mutation of the BRCA1 gene, which sharply increases her risk of developing breast cancer and ovarian cancer."My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman," Jolie wrote. "Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy."

Videos.

Page 3: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

http://www.cnn.com/2013/05/14/showbiz/angelina-jolie-double-mastectomy

• Angelina Jolie’s double mastectomy puts genetic testing in the spotlight.  What her choice reveals about calculating risk, cost and peace of mind.  

Page 4: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

http://www.cnn.com/2013/05/14/showbiz/angelina-jolie-double-mastectomy

STORY HIGHLIGHTS• A blood test can detect if a woman 

is "highly susceptible" to breast or ovarian cancer

• Jolie reveals she carries a gene that increases her risk for cancer

• Her mother died of ovarian cancer in 2007

Page 5: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Risky BusinessMy doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman," Jolie wrote.

• What does “percent risk” mean?• What does this mean for you?• What are your risk factors?

Page 6: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Overview

• About cancer• About mutations• About BRCA1 gene.• Genetic testing• SNPs, GWAS.

Background materials:www.cancerquest.org...

Page 7: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Definitions

• Risk• Relative risk• Increased risk, Decreased risk

• Incidence• Mortality

First we will look at incidence.

Page 8: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

DATACenters for Disease Control and PreventionU.S. Cancer Statistics: An Interactive Atlas 

http://apps.nccd.cdc.gov/DCPC_INCA/DCPC_INCA.aspx

United States Cancer Statistics (USCS)View Data Online1999–2009 Cancer Incidence and Mortality DataThis Web-based report includes the official federal statistics on cancer incidence from registries that have high-quality data and cancer mortality statistics for each year and 2005–2009 combined. It is produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), in collaboration with the North American Association of Central Cancer Registries (NAACCR).

Page 9: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

DATACenters for Disease Control and PreventionU.S. Cancer Statistics:  An Interactive Atlas

Cancer Event:  Incidence rate or Death rate.Site:  Female BreastRace / Ethnicity:  Black or WhitePeriod:  1999 or 2009.U.S. State:  Georgia or Maryland 

http://apps.nccd.cdc.gov/DCPC_INCA/DCPC_INCA.aspx

Page 10: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Examine the map. Collect the data.

Repeat for Race / Ethnicity:  White

Repeat for Death Rate.

Repeat for second state.

Collect data using the following parameters.Cancer Event:  Incidence rate.Site:  Female BreastRace / Ethnicity:  BlackPeriod:  1999 or 2009.U.S. State:  your state.

http://apps.nccd.cdc.gov/DCPC_INCA/DCPC_INCA.aspx

You will be collecting two sets of data.Select two states of interest for comparison.

Type data set into Excel worksheet.

Page 11: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Breast cancer IncidentGeorgia  year rate count population Rank out of                          White 2009 120.9 4348 3221000 21 50Black 2009 126.1 1754 1594705 30 38             White  1999 127.4 3662 2756311 7 45Black 1999 103.2 985 1239075 7 34

             

Breast cancer Incident 

Massachusetts rate count population Rank out of

Year

White 2009 132.8 4835 2940746 42 50

Black 2009 107.2 225 254227 6 38

White  1999 147.4 4953 2921658 38 45

Black 1999 96.6 152 216145 3 34

Page 12: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

• Incidence Rate

• Death RateGA wh 1999 GA wh 2009 MA wh 1999 MA wh 2009

0

20

40

60

80

100

120

140

160

WhiteBlack

GA wh 1999 GA wh 2009 MA wh 1999 MA wh 20090

5

10

15

20

25

30

35

WhiteBlack

Breast Cancer, Georgia versus Massachusetts White and Black,   Year 1999 versus 2009

Page 13: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Questions? Questions?• Is the incidence of breast cancer the same for

each group?• Has the incidence of breast cancer for your

group increased or decreased between 1999 and 2009?

• Has the death rate changed?• For each group has the incidence and death

rate changed in the same direction?• New questions?

Page 14: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Uncertainty is normally an intrinsic feature of some part of nature ----- it is the same for all observers.  

Risk is specific to a person -- it is not the same for all observers.  The possibility of rain tomorrow is uncertain for everyone; but the risk of getting wet is specific to me. 

Taken from: http://www.solver.com/risk-analysis-tutorial

Page 15: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Risk vs. Benefits?

Risk is determined by two factors: • How often might a particular hazard arise?• How much harm is likely to result? 

List small risks you take everyday? What are the benefits?  Are the risks worth the benefits?

Page 16: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Risk analysis is the systematic study of uncertainties and risks we encounter in business, engineering, public policy, and many other areas.  

Many, but not all, risks involve choices.  By taking some action, we may deliberately expose ourselves to risk. 

Page 17: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

http://mathbench.umd.edu/homepage/prob_stat.htm

TUTORIAL 

Page 18: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

http://mathbench.umd.edu/homepage/prob_stat.htm

Page 19: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

E.Singletary, 2003, Rating the Risk Factors for Breast Cancer

Page 20: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?
Page 21: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies.

Am J Clin Nutr 2012;95(3):713-25. doi: 10.3945/ajcn.111.014415.http://www.ncbi.nlm.nih.gov/pubmed/22277553 • Entire study has ~1 million participants• Individual studies range from 6,000

participants to 200,000 participants

Page 22: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Questions? Questions?

• Find one study that has a “tight” calculation of risk.

• Discuss how risks are calculated• Explain variance• Why are there different studies?• Evaluate.• Ethics in study.• What study would you design?

Page 23: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Overview

• Risk assessment • Beyond the Human 

Genome Project:• Personal Genomes• Microarray analysis

Background materials:

Singletary, 2003

www.personalgenomes.org/

Dorit, 2007

Microarray animations by Davidson.

Page 24: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Risk Factors• Factors such as alcohol consumption and obesity appear to have only a 

small to moderate effect on breast cancer risk. •  • Hormone replacement therapy and nulliparity have a larger but still 

rather moderate effect on breast cancer incidence.•  • Age is the most reliable factor associated with increased risk of breast 

cancer.

• Besides age, only familial history of cancer (e,g, mother or sibling having had breast cancer) together with a specific BRCA mutation  correlates with a large-fold increase in risk for breast cancer.

• But only 5-10% of breast cancer cases are familial. 

Page 25: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?
Page 26: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?
Page 27: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Cancer Subtypes (1)• A better understanding of heterogeneity within breast cancer cells 

themselves is important as there are subpopulations of breast cancers:

 • Breast cancers differ in terms of their specific mutations within 

tumor suppressor genes such as BRCA1 (that can no longer prevent cancer) 

and • oncogenes such as estrogen receptor and the epidermal growth 

factor receptor HER2 (that promote cancer cell abnormal cell division) that lead to malignant cancer

 

Page 28: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

• Increase in personal/individual genomes could provide further clues to cancer risk: 

• Having a larger and more varied group of individuals whose entire genome is known and whose cancer incidence can be followed would better identify gene clusters associated with cancer risk.

Page 29: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

• A better understanding of heterogeneity within breast cancer cells themselves is important as there are subpopulations of breast cancers:

 • Breast cancer cells differ in terms of other genes that 

are upregulated and downregulated. These gene expression profiles not only define subpopulations of breast cancer cells but also provide clues to optimal therapy for the specific subtype of cancer. This could improve treatment and prognosis.

Cancer Subtypes (2)

Page 30: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Microarray Analysis

Page 31: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Lab activity match the cDNAs to the oligonucleotides in the 

wells  (Carolina Biologicals) 

Page 32: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

Dorit, 2007

Page 33: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

For confirmation of gene expression: Multiblot Western Blots for protein expression (Kinexus)

Page 34: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

• What factors make breast cancer risk assessment so difficult?

• Why might this improve in the near future?• What types of genes are involved in cells 

becoming cancerous?• What types of genes contribute to cancer 

pathology?

Page 35: PROBLEM SPACE  Breast  Cancer:  What Are The Risks?

BibliographyU.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2009 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2013. Available at: www.cdc.gov/uscs.

Breast Cancer The Angelina Effect: TIME’s New Cover Image Revealed. By Jeffrey Kluger May 15, 2013.   http://healthland.time.com/2013/05/15/the-angelina-effect-times-new-cover-image-revealed/#ixzz2WF6pF41U. 

www.cancerquest.orghttp://www.solver.com/risk-analysis-tutorial

http://mathbench.umd.edu/homepage/prob_stat.htmwww.personalgenomes.org/ Am J Clin Nutr 2012;95(3):713-25. doi: 10.3945/ajcn.111.014415.http://www.ncbi.nlm.nih.gov/pubmed/22277553